CHRISTOPHER GOMEZ: Open Payments
NPI 1871215723 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 16 payments from 8 companies in 2025. Trend: 2023 $231 · 2024 $498 · 2025 $426
Food & beverage: $341Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $147 |
| ABBVIE INC. | 5 | $111 |
| UROGEN PHARMA, INC. | 2 | $55 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $26 |
| 180 Medical, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $22 |
| KOELIS Inc. | 1 | $19 |
Products named: ERLEADA, BOTOX, ZUSDURI, PYLARIFY, GENTLECATH GLIDE, GEMTESA, General - Vascular Intervention, EPKINLY.
Industry payments across AZ — which companies pay providers there.
